Cargando…

Thrombolysis: Biological and Therapeutic Properties of New Thrombolytic Agents

Detalles Bibliográficos
Autor principal:	Chen, Fabian
Formato:	Texto
Lenguaje:	English
Publicado:	1987
Materias:	Book Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2590105/

Ejemplares similares

Thrombolytic Agents: Nanocarriers in Targeted Release
por: Shen, Minghua, et al.
Publicado: (2021)

Structural Biology and Protein Engineering of Thrombolytics
por: Mican, Jan, et al.
Publicado: (2019)

Successful thrombolysis with low dose thrombolytic agent in a patient with acute life-threatening massive pulmonary thromboembolism: A case report
por: Adhikari, Sagar, et al.
Publicado: (2022)

Acrylonitrile adducts: design, synthesis and biological evaluation as antimicrobial, haemolytic and thrombolytic agent
por: Das, Parineeta, et al.
Publicado: (2023)

Thrombolytic Dilemma: A Case Report of Early Puerperium Ischemic Stroke Treated With Intravenous Thrombolysis
por: Santos, André, et al.
Publicado: (2023)

Tenecteplase or Alteplase: What Is the Thrombolytic Agent of the Future?
por: Mahmood, Ammad, et al.
Publicado: (2022)

Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers
por: Zhou, Yanfeng, et al.
Publicado: (2019)

Predictive role of pre-thrombolytic hs-CRP on the safety and efficacy of intravenous thrombolysis in acute ischemic stroke
por: Cheng, Xu-Dong, et al.
Publicado: (2023)

Review of Stroke Thrombolytics
por: Bivard, Andrew, et al.
Publicado: (2013)

A Manual of Biological Therapeutics
por: Duggan, Malone
Publicado: (1915)

Molecular Approaches to Developmental Biology
por: Chen, Fabian
Publicado: (1987)

Development and Testing of Thrombolytics in Stroke
por: Nikitin, Dmitri, et al.
Publicado: (2021)

Epigenomics: From Chromatin Biology to Therapeutics
por: Schmidt, Barbara
Publicado: (2013)

A Notable Book on Biological Therapeutics
Publicado: (1914)

Assessment of Toxic Agents at the Workplace: Roles of Ambient and Biological Monitoring
por: Posner, H. S.
Publicado: (1985)

Perspectives in Inflammation, Neoplasia, and Vascular Cell Biology
por: Chen, Fabian
Publicado: (1988)

Combining Intravenous Thrombolysis and Antithrombotic Agents in Stroke: An Update
por: Derex, Laurent, et al.
Publicado: (2018)

Systemic thrombolysis with newer thrombolytics vs anticoagulation in acute intermediate risk pulmonary embolism: a systematic review and meta-analysis
por: Mathew, Don, et al.
Publicado: (2023)

Book Reviews: Evaluating and Standardizing Therapeutic Agents, 1890–1950
por: Löwy, Ilana
Publicado: (2011)

Effect of Fermentation Parameters on Natto and Its Thrombolytic Property
por: Yang, Yun, et al.
Publicado: (2021)

Marine Microbial Fibrinolytic Enzymes: An Overview of Source, Production, Biochemical Properties and Thrombolytic Activity
por: Barzkar, Noora, et al.
Publicado: (2022)

In Silico Study of Different Thrombolytic Agents for Fibrinolysis in Acute Ischemic Stroke
por: Yang, Yilin, et al.
Publicado: (2023)

Prions: The New Biology of Proteins
por: Belay, Ermias D.
Publicado: (2007)

Aspect of Thrombolytic Therapy: A Review
por: Ali, Md. Ramjan, et al.
Publicado: (2014)

Recent strategies on targeted delivery of thrombolytics
por: Huang, Ting, et al.
Publicado: (2019)

Post-Thrombolytic D-Dimer Elevation Predicts Symptomatic Intracranial Hemorrhage and Poor Functional Outcome After Intravenous Thrombolysis in Acute Ischemic Stroke Patients
por: Jin, Tianyu, et al.
Publicado: (2022)

Toward a New Philosophy of Biology: Observations of an Evolutionist
por: Chen, May C.
Publicado: (1990)

Thrombolytic Enzymes of Microbial Origin: A Review
por: Diwan, Deepti, et al.
Publicado: (2021)

Comparative Efficacy and Safety of Thrombolytic Agents for Pulmonary Embolism: A Bayesian Network Meta-Analysis
por: Li, Hong-Yan, et al.
Publicado: (2023)

Anticancer and Interferon Agents: Synthesis and Properties - Drugs and Parmacutical Sciences - Vol. 24
por: Fox, B.W.
Publicado: (1985)

The Biology of Cancer—A new Approach
por: Peto, J.
Publicado: (1976)

Intracoronary arterial retrograde thrombolysis with percutaneous coronary intervention: a novel use of thrombolytic to treat acute ST-segment elevation myocardial infarction
por: Tian, Jin-Wen, et al.
Publicado: (2019)

New Thrombolytic Infusion Application of Dissolving Renal Artery Embolic Thrombosis: Low-Dose Slow-Infusion Thrombolytic Therapy
por: Karakurt, Ahmet
Publicado: (2018)

Encapsulation of Biological Agents in Hydrogels for Therapeutic Applications
por: Pérez-Luna, Víctor H., et al.
Publicado: (2018)

Targeted Delivery of Plasminogen Activators for Thrombolytic Therapy: An Integrative Evaluation
por: Ma, Yunn-Hwa, et al.
Publicado: (2019)

Comparison of therapeutic effect of catheter direct thrombolysis and peripheral venous thrombolysis on acute pulmonary embolism
por: Guan, Qinglong, et al.
Publicado: (2023)

A Syllabus of New Remedies and Therapeutic Measures: With Chemistry, Physical Appearance and Therapeutic Application
Publicado: (1901)

Response to thrombolytic agents in acute myocardial infarction in opium abusers versus non-abusers
por: Jazi, Seyed Mohammad Hashemi, et al.
Publicado: (2012)

Improper Use of Thrombolytic Agents in Acute Hemiparesis Following Misdiagnosis of Acute Ischemic Stroke
por: Kim, Min Chan, et al.
Publicado: (2018)

Recombinant Expression of Thrombolytic Agent Reteplase in Marine Microalga Tetraselmis subcordiformis (Chlorodendrales, Chlorophyta)
por: Wu, Chunhui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2mvjdp9o1fgpqmric502fpf4lr